Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Venderbos, Lionne"'
Autor:
Venderbos, Lionne D. F.1,2, Bergh, Roderick C. N.1, Roobol, Monique J.1, Schröder, Fritz H.1, Essink‐Bot, Marie‐Louise2,3, Bangma, Chris H.1, Steyerberg, Ewout W.2, Korfage, Ida J.2
Publikováno v:
Psycho-Oncology. Mar2015, Vol. 24 Issue 3, p348-354. 7p. 1 Diagram, 2 Charts, 1 Graph.
Publikováno v:
BMC Cancer, 16:586. BioMed Central Ltd.
Ruane-McAteer, E, O'Sullivan, J, Porter, S, Venderbos, L & Prue, G 2016, ' An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol ', BMC Cancer, vol. 16, 586 . < http://10.1186/s12885-016-2605-6 >
Ruane-McAteer, E, O'Sullivan, J, Porter, S, Venderbos, L & Prue, G 2016, ' An exploration of men's experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol ', BMC Cancer, vol. 16, 586 . https://doi.org/10.1186/s12885-016-2605-6
Ruane-McAteer, E, O'Sullivan, J, Porter, S, Venderbos, L & Prue, G 2016, ' An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol ', BMC Cancer, vol. 16, 586 . < http://10.1186/s12885-016-2605-6 >
Ruane-McAteer, E, O'Sullivan, J, Porter, S, Venderbos, L & Prue, G 2016, ' An exploration of men's experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol ', BMC Cancer, vol. 16, 586 . https://doi.org/10.1186/s12885-016-2605-6
BackgroundProstate cancer is one of the most common male cancers worldwide. Active Surveillance (AS) has been developed to allow men with lower risk disease to postpone or avoid the adverse side effects associated with curative treatments until the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d868a499d654cac25081f2e5dc135d92
https://pure.eur.nl/en/publications/b98929a9-78aa-4ed1-aac2-c54e0918d656
https://pure.eur.nl/en/publications/b98929a9-78aa-4ed1-aac2-c54e0918d656
Autor:
van Vugt, Heidi A.1,2 h.a.vanvugt@erasmusmc.nl, Roobol, Monique J.1, Venderbos, Lionne D.F.1, Joosten-van Zwanenburg, Evelien3, Essink-Bot, Marie-Louise2,4, Steyerberg, Ewout W.2, Bangma, Chris H.1, Korfage, Ida J.2
Publikováno v:
European Journal of Cancer. Feb2010, Vol. 46 Issue 3, p669-677. 9p.